(PubMed) MacLennan SC, Wade FM, Forrest KM, Ratanayake PD, Fagan E, Antony J
Key Takeaways A recent study shows GLP-1 use is linked to fewer emergency room visits and hospitalizations
It also lists gut motility patterns, the underlying cause of the obesity, and existing medication interactions as sources of variation
[18] mhra.gov.uk or via the Yellow Card app
It is also noted that counteracting mitochondrial OS by means of ExAs has led to the prevention of podocyte loss, albuminuria, and glomerulosclerosis, improving renal function
GLP-1 medications, often referred to as GLP-1 agonists, are a type of medications that help manage blood sugar levels in people with Type 2 diabetes, and they are also used to treat obesity